Methylation and Survival in Lung Cancer
Author Information
Author(s): Toyooka S, Suzuki M, Maruyama R, Toyooka K O, Tsukuda K, Fukuyama Y, Iizasa T, Aoe M, Date H, Fujisawa T, Shimizu N, Gazdar A F
Primary Institution: University of Texas Southwestern Medical Center
Hypothesis
The study investigates the correlation between the methylation status of specific genes and the survival of patients with non-small-cell lung cancer.
Conclusion
Methylation of the p16INK4a gene is associated with poor survival in patients with lung adenocarcinoma.
Supporting Evidence
- Methylation of p16INK4a was associated with poor survival in adenocarcinoma patients.
- Univariate analysis showed that p16INK4a methylation was significantly correlated with poor prognosis.
- Multivariate analysis confirmed p16INK4a methylation as an independent prognostic factor.
Takeaway
This study found that a specific change in DNA called methylation can make lung cancer patients live shorter lives, especially if it happens to a gene called p16INK4a.
Methodology
The study analyzed the methylation status of five genes in frozen tumor specimens from patients with non-small-cell lung cancer and correlated it with survival data.
Limitations
The study is limited to Japanese patients and may not be generalizable to other populations.
Participant Demographics
The participants included 234 males and 117 females with a median age of 65 years.
Statistical Information
P-Value
0.020
Confidence Interval
95% CI, 1.10–3.00
Statistical Significance
p=0.020
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website